Chemical genetic screening identifies tricyclic compounds that decrease cellular melanin content

Journal of Investigative Dermatology

Volumn 128, Issue 5, 2008, Pages 1236-1247

  Ni Komatsu, Li ^a   Orlow, Seth J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CHLORPROTHIXENE; CLOMIPRAMINE; CLOZAPINE; CYCLOBENZAPRINE; CYPROHEPTADINE; DESIPRAMINE; DIZOCILPINE; DOXEPIN; IMIPRAMINE; LOXAPINE SUCCINATE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAPROTILINE; MELANIN; MONOPHENOL MONOOXYGENASE; NORTRIPTYLINE; ORPHENADRINE; PROMAZINE; PROTRIPTYLINE; THIAZINAMIUM; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE MALEATE; TRIPELENNAMINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CHEMICAL GENETICS; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; GENETIC IDENTIFICATION; GENETIC SCREENING; HYPERPIGMENTATION; IC 50; IMMUNOFLUORESCENCE; MELANOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 42149089346     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701163     Document Type: Article

References (69)

1. Abramowitz J, Chavin W (1980) Acute effects of two melanocytolytic agents, hydroquinone and beta-mercaptoethanolamine, upon tyrosinase activity and cyclic nucleotide levels in murine melanomas. Chem Biol Interact 32:195-208
2. Berson JF, Frank DW, Calvo PA, Bieler BM, Marks MS (2000) A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature. J Biol Chem 275:12281-9
3. Boissy RE, Zhao Y, Gahl WA (1998) Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking. Lab Invest 78:1037-48
4. Briganti S, Camera E, Picardo M (2003) Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16:101-10
5. Bürgi S, Baltensperger K, Honegger UE (2003) Antidepressant-induced switch of beta 1-adrenoceptor trafficking as a mechanism for drug action. J Biol Chem 278:1044-52
6. Chen K, Manga P, Orlow SJ (2002) Pink-eyed dilution protein controls the processing of tyrosinase. Mol Biol Cell 13:1953-64
7. Costin G-E, Valencia JC, Vieira WD, Lynn Lamoreux M, Hearing VJ (2003) Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. J Cell Sci 116:3203-12
8. Cullen MK (1998) Genetic epidermal syndromes: disorders characterized by lentigines. In: The pigmentary system: physiology and pathophysiology. (James J. Nordlund, Raymond E. Boissy, Vincent J. Hearing, Richard A. King, Jean-Paul Ortonne, eds), New York: Oxford University Press, 760-6
9. Curto EV, Kwong C, Hermersdorfer H (1999) Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem Pharmacol 15:663-72
10. Dell'Angelica EC (2003) Melanosome biogenesis: shedding light on the origin of an obscure organelle. Trends Cell Bio 13:503-6
11. Diment S, Eidelman M, Rodriguez GM, Orlow SJ (1995) Lysosomal hydrolases are present in melanosomes and are elevated in melanizing cells. J Biol Chem 270:4213-5
12. Drake LA, Cohen L, Gillies R, Flood JG, Riordan AT, Phillips SB et al. (1999) Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis. J Am Acad Dermatol 41:209-14
13. Drake LA, Millikan LE (1995) The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin study group. Arch Dermatol 131:1403-8
14. Goodman LS, Gilman A (1996) The pharmacological basis of therapeutics, 9th edn, New York, NY: McGraw-Hill Company
15. Hall AM, Krishnamoorthy L, Orlow SJ (2003) Accumulation of tyrosinase in the endolysosomal compartment is induced by U18666A. Pigment Cell Res 16:149-58
16. Hall AM, Orlow SJ (2005) Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation. Pigment Cell Res 18:122-9
17. Han R, Baden HP, Brissette JL, Weiner L (2002) Redefining the skin's pigmentary system with a novel tyrosinase assay. Pigment Cell Res 15:290-7
18. Hearing VJ (1987) Mammalian monophenol monooxygenase (tyrosinase): purification, properties, and reactions catalyzed. Methods Enzymol 142:154-65
19. Hearing VJ (2005) Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci 37:3-14
20. Honegger UE, Roscher AA, Wiesmann UN (1983) Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. J Pharmacol Exp Ther 225:436-41
21. Hurwitz R, Ferlinz K, Sandhoff K (1994) The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler 375:447-50
22. Jimbow K, Quevedo WC Jr, Fitzpatrick TB, Szabo G (1976) Some aspects of melanin biology: 1950-1975. J Invest Dermatol 67:72-89
23. Jimenez M, Tsukamoto K, Hearing VJ (1991) Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 266:1147-56
24. Jimenez-Cervantes C, Valverde P, Garcia-Borron JC, Solano F, Lozano JA (1993) Improved tyrosinase activity stains in polyacrylamide electrophoresis gels. Pigment Cell Res 6:394-9
25. Jung DW, Williams D, Khersonsky SM, Kang TW, Heidary N, Chang YT et al. (2005) Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol Biosyst 1:85-92
26. Khersonsky SM, Chang YT (2004) Strategies for facilitated forward chemical genetics. Chembiochem 5:903-8
27. Kim Y-J, Uyama H (2005) Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci 62:1707-23
28. Kolzer M, Werth N, Sandhoff K (2004) Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. FEBS Lett 559:96-8
29. Korner A, Pawelek J (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217:1163-5
30. Marks MS, Seabra MC (2001) The melanosome: membrane dynamics in black and white. Nat Rev Mol Cell Biol 2:738-48
31. McCleane G (2000) Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 49:574-9
32. McEwan M, Parsons PG (1987) Inhibition of melanization in human melanoma cells by a serotonin uptake inhibitor. J Invest Dermatol 89:82-6
33. Metelitsa AI, Nguyen GK, Lin AN (2005) Imipramine-induced facial pigmentation: case report and literature review. J Cutan Med Surg 9:341-5
34. Ming ME, Bhawan J, Stefanato CM, McCalmont TH, Cohen LM (1999) Imipramine-induced hyperpigmentation: four cases and a review of the literature. J Am Acad Dermatol 40:159-66
35. Ni-Komatsu L, Leung JK, Williams D, Min J, Khersonsky SM, Chang YT et al. (2005) Triazine-based tyrosinase inhibitors identified by chemical genetic screening. Pigment Cell Res 18:447-53
36. Ni-Komatsu L, Orlow SJ (2006) Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression. Exp Eye Res 82:519-28
37. Ni-Komatsu L, Orlow SJ (2007) Identification of novel pigmentation modulators by chemical genetic screening. J Invest Dermatol 127:1585-92
38. Orlow SJ (1995) Melanosomes are specialized members of the lysosomal lineage of organelles. J Invest Dermatol 105:3-7
39. Palmeri S, Mangano L, Battisti C, Malandrini A, Federico A (1992) Imipramine induced lipidosis and dexamethasone effect: morphological and biochemical study in normal and chronic GM2 gangliosidosis fibroblasts. J Neurol Sci 110:215-21
40. Parvez S, Kang M, Chung HS, Cho C, Hong MC, Shin MK et al. (2006) Survey and mechanism of skin depigmenting and lightening agents. Phytother Res 20:921-34
41. Penney KB, Smith CJ, Allen JC (1984) Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol 82:308-10
42. Potterf SB, Furumura M, Sviderskaya EV, Santis C, Bennett DC, Hearing VJ (1998) Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes. Exp Cell Res 244:319-26
43. Raposo G, Marks MS (2002) The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3:237-48
44. Richmond B, Huizing M, Knapp J, Koshoffer A, Zhao Y, Gahl WA et al. (2005) Melanocytes derived from patients with Hermansky-Pudlak syndrome types 1, 2, and 3 have distinct defects in cargo trafficking. J Invest Dermatol 124:420-7
45. Roff CF, Goldin E, Comly ME, Cooney A, Brown A, Vanier MT et al. (1991) Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev Neurosci 13:315-9
46. Sato M, Akaboshi S, Katsumoto T, Taniguchi M, Higaki K, Tai T et al. (1998) Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C. Brain Dev 20:50-2
47. Schreiber SL (2003) The small-molecule approach to biology. Chem Eng News 81:51-61
48. Seiji M, Shimao K, Birbeck MS, Fitzpatrick TB (1963) Subcellular localization of melanin biosynthesis. Ann NY Acad Sci 100:497-533
49. Shen B, Samaraweera P, Rosenberg B, Orlow SJ (2001) Ocular albinism type 1: more than meets the eye. Pigment Cell Res 14:243-8
50. Sicari MC, Lebwohl M, Baral J, Wexler P, Gordon RE, Phelps RG (1999) Photoinduced dermal pigmentation in patients taking tricyclic antidepressants: histology, electron microscopy, and energy dispersive spectroscopy. J Am Acad Dermatol 40:290-3
51. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155-228
52. Slominski A, Wortsman J, Tobin DJ (2005) The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J 19:176-94
53. Smukste I, Stockwell BR (2005) Advances in chemical genetics. Annu Rev Genomics Hum Genet 6:262-86
54. Snyder JR, Hall A, Ni-Komatsu L, Khersonsky SM, Chang YT, Orlow SJ (2005) Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. Chem Biol 12:477-84
55. Solano F, Briganti S, Picardo M, Ghanem G (2006) Hypopigmentation agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 19:550-71
56. Spritz RA, Chiang P-W, Oiso N, Alkhateeb A (2003) Human and mouse disorders of pigmentation. Curr Opin Genet Dev 13:284-9
57. Tan DS (2002) Sweet surrender to chemical genetics. Nat Biotechnol 20:561-3
58. Toplak H, Zuehlke R, Loidl S, Hermetter A, Honegger UE, Wiesmann UN (1990) Single and multiple desipramine exposures of cultured cells. Changes in cellular anisotropy and in lipid composition of whole cells and of plasma membranes. Biochem Pharmacol 39:1437-43
59. Toyofuku K, Valencia JC, Kushimoto T, Costin GE, Virador VM, Vieira WD et al. (2002) The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res 15:217-24
60. Toyofuku K, Wada I, Hirosaki K, Park JS, Hori Y, Jimbow K (1999) Promotion of tyrosinase folding in COS 7 cells by calnexin. J Biochem (Tokyo) 125:82-9
61. Tripathi RK, Hearing VJ, Urabe K, Aroca P, Spritz RA (1992) Mutational mapping of the catalytic activities of human tyrosinase. J Biol Chem 267:23707-12
62. Urabe K, Nakayama J, Hori Y (1998) Mixed epidermal and dermal hypermelanoses. In: The pigmentary system: physiology and pathophysiology. (James J. Nordlund, Raymond E. Boissy, Vincent J. Hearing, Richard A. King, Jean-Paul Ortonne, eds), New York: Oxford University Press, 909-11
63. Wei ML (2006) Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res 19:19-42
64. 0 ATPase by screening a triazine library for correction of albinism. Chem Biol 11:1251-9
65. Winder AJ (1991) Expression of a mouse tyrosinase cDNA in 3T3 Swiss mouse fibroblasts. Biochem Biophys Res Commun 178:739-45
66. Winder AJ, Wittbjer A, Rosengren E, Rorsman H (1993a) Fibroblasts expressing mouse c locus tyrosinase produce an authentic enzyme and synthesize phaeomelanin. J Cell Sci 104:467-75
67. Winder AJ, Wittbjer A, Rosengren E, Rorsman H (1993b) The mouse brown (b) locus protein has dopachrome tautomerase activity and is located in lysosomes in transfected fibroblasts. J Cell Sci 106:153-66
68. Zhao H, Boissy YL, Abdel-Malek Z, King RA, Nordlund JJ, Boissy RE (1994) On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. Lab Invest 71:25-34
69. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35-44